Hoya Reports Solid Q2 2017 Gains in Eyeglass Sales

Tuesday, October 31 2017 | 00 h 00 min | Financial News, News, Press Release

HOYA reported strong sales of eyeglass lenses within the Americas in their Q2 2017 sales amid what they describe as a “challenging market”, recording growth of 6%, while Asia/Oceania was up 6%. Sales in Japan declined, though the prices for eyeglass lenses have stabilized.

Performance in Europe was reported to be unsatisfactory by Hoya, citing changes in insurance plans in France leading to lower performance, driving down HOYA earnings in Europe. Contact lens sales improved globally between 5% and 6% year on year.

HOYA expects profits to improve in the second half of 2017 thanks to fewer mergers and acquisitions costs.

Read the complete press release HERE.

Featured Posts

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read more

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read more

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read More

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read More

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read More

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read More

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read more

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read more

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more

Opticians Association of Canada Elections: Cast Your Vote Now!

The Opticians Association of Canada (OAC) is excited to announce the start of its provincial board of directors' elections for Ontario, Quebec, and Newfoundland & Labrador.

Learn More

ClearVision Celebrates Highest Finish Yet with Ninth Best Companies to Work for in New York Award

ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Read more

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Read more

Marchon Victoria Beckham

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Read more

Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

Read more